title: Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.
authors.forename: Resat
authors.initials: R
authors.lastname: Ozaras
authors.forename: Mucahit
authors.initials: M
authors.lastname: Yemisen
authors.forename: Bilgul
authors.initials: B
authors.lastname: Mete
authors.forename: Ali
authors.initials: A
authors.lastname: Mert
authors.forename: Recep
authors.initials: R
authors.lastname: Ozturk
authors.forename: Fehmi
authors.initials: F
authors.lastname: Tabak
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003490:Cyanosis / Q000139:chemically induced*; D003840:Deoxycholic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D004338:Drug Combinations; D005385:Fingers / Q000473:pathology; D006225:Hand / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy; D010713:Phosphatidylcholines / Q000008:administration & dosage*; D010715:Phosphatidylglycerols / Q000008:administration & dosage*
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination